Research
The URMC has a long and distinguished track record in HIV/AIDS research, dating back to the earliest days of the epidemic. UR was also a founding member of both the HIV Vaccine Trials Network (HVTN) and the AIDS Clinical Trials Group (ACTG), or their preceding organizations, and has a proud tradition of vaccine research – including the invention of ground-breaking technologies that were commercially licensed to develop the human papillomavirus (HPV) vaccines that are now used worldwide to protect against cervical and anogenital cancers.
The CFAR serves as an anchor for HIV/AIDS researchers at the URMC and a catalyst for innovation by providing leadership and infrastructure to create new interdisciplinary collaborations which result in high-impact research. View recent publications.
Latest Headlines
-
UR Named Center for AIDS Research by the National Institutes of Health »
May 09, 2013 -
As Our Understanding of HIV Evolves, Grant Helps Providers Keep Pace »
February 19, 2013 -
URMC Observes World AIDS Day with Talks, Events, Concert »
November 19, 2012 -
URMC Observes HIV Vaccine Awareness Day with Events »
May 11, 2012 -
New Fund Will Support Early Stage Drug Discovery »
April 09, 2012
Upcoming Events
Justice Involved Women Conference
Join us for the June 21st Justice Involved Women Conference where researchers, practitioners and policy makers will present their work to disseminate evidence-based practices and interventions for justice involved women. Other discussion topics will include the state of the science, difficulties for informing practice, funding challenges and solutions for justice involved women. Click here to learn more.
